PMC:7441788 / 15453-15625 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T200","span":{"begin":36,"end":41},"obj":"Chemical"},{"id":"T201","span":{"begin":80,"end":85},"obj":"Chemical"},{"id":"T202","span":{"begin":121,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A202","pred":"chebi_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"day mortality rate in the high-dose group was more than double that in low-dose group (39.0% vs. 16.0%). The high-dosage group exhibited more instance of corrected QT (QTc)"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"778","span":{"begin":4,"end":13},"obj":"Disease"}],"attributes":[{"id":"A778","pred":"pubann:denotes","subj":"778","obj":"MESH:D003643"}],"text":"day mortality rate in the high-dose group was more than double that in low-dose group (39.0% vs. 16.0%). The high-dosage group exhibited more instance of corrected QT (QTc)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"778","span":{"begin":4,"end":13},"obj":"Disease"}],"attributes":[{"id":"A778","pred":"tao:has_database_id","subj":"778","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"day mortality rate in the high-dose group was more than double that in low-dose group (39.0% vs. 16.0%). The high-dosage group exhibited more instance of corrected QT (QTc)"}